Needham & Company LLC Reiterates Buy Rating for Artiva Biotherapeutics (NASDAQ:ARTV)
Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They presently have a $23.00 price target on the stock. Separately, HC Wainwright began coverage on shares of Artiva Biotherapeutics in a research report on Monday, December […]
Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They presently have a $23.00 price target on the stock. Separately, HC Wainwright began coverage on shares of Artiva Biotherapeutics in a research report on Monday, December […]
